Press Release
Contact(s):
Joycelyn Woods MA-CMA (212) 595-NAMA/6262
Fred Christie AFIRM (516) 897-1330
Chris Kelly ARM (202) 246-6850
For Release:
December 29, 2006
Call for Nominations of the
Richard Lane Patient Advocacy Award
The National Alliance of Methadone Advocates (NAMA) in collaboration with Advocates for the Integration of Methadone and Recovery (AFIRM) and Advocates for Recovery with Medication (ARM) is seeking Nominations for the Richard Lane Patient Advocacy Award to be presented by the American Association for the Treatment of Opioid Dependence (AATOD) at the 2007 National Conference.
The award will be presented during the Conference Banquet to be held in San Diego (October 20-24, 2007). The recipient will receive roundtrip Coach Class airfare to the conference, two (2) nights in the hotel and full conference registration.
Richard Land was a long-term heroin user who, upon release from prison in 1967, was instrumental in establishing one of the Nation’s first methadone treatment programs. In 1974, he became the Executive Director of Man Alive (Baltimore) and later served as Vice President of the American Methadone Treatment Association and as Vice Chairman of the Governor’s Council on Alcohol and Drug Abuse in Maryland. Mr. Lane was a passionate advocate for methadone treatment and, by disclosing his own treatment experiences, provided inspiration to patients and colleagues alike. This award was established in 1995 and recognizes extraordinary achievements in patient advocacy.
The following criteria should be applied in making the selection:
Only one (1) nominee can be submitted to the AATOD Conference Awards Committee. There may be a number of nominees, who will be fielded by The Committee in the methadone patient advocacy movement, however, The Committee will be responsible for submitting only one (1) “consensus” nominee to receive this honor.
The nominee must have been involved in the field of methadone advocacy for a period of five (5) years.
The nominee must have been actively engaged in methadone advocacy for a period of five (5) years.
The nominee must have made meaningful and consistent contributions, which have had a significant impact on opioid treatment within a state or region of the United States.
The Committee will be responsible for completing the nomination form and retaining letters of support describing the nominee’s achievements, which are required before any final nomination can be submitted to the AATOD Awards Committee.
All submissions should include the completed Richard Land Patient Advocacy Award Nomination Form that is included.
Please distribute to all interested persons.
Download Press Release
Posts
